期刊文献+

基层医院重症监护病房鲍曼不动杆菌感染特征分析 被引量:4

Clinical distribution and antibiotic resistance of acinetobacter baumannii in ICU
原文传递
导出
摘要 目的了解基层医院重症监护病房(ICU)鲍曼不动杆菌感染的分布特点及其耐药谱变化。方法采用回顾性调查方法 ,对浙江省仙居县人民医院2005年1月~2007年12月ICU送检样品中分离得到的239株鲍曼不动杆菌药敏试验及感染患者的临床资料进行统计分析。结果 2005-2007年鲍曼不动杆菌检出率分别为9.04%,18.76%,17.75%;样品主要来源于痰(235/239,98.33%);年龄〉60岁患者占74.48%;患者平均住院时间中位数为23 d;鲍曼不动杆菌对13种抗菌药物的耐药率逐年增高。结论 ICU患者中鲍曼不动杆菌检出率、耐药率呈逐年上升趋势。ICU应严格执行准入制度,慎重合理使用三、四代头孢及碳青霉烯类抗菌药物,加强手卫生及消毒隔离,减少耐药菌株的产生和传播。 Objective To identify the distribution characteristics and drug resistance of Acinetobacter baumannii in the ICU of a local hospital.Methods Two hundred and thirty-nine strains of Acinetobacter baumannii were isolated from January 2005 to December 2007.The drug susceptibility testing and clinical data were retrospectively analyzed.Results The strains were mainly isolated from sputum specimeins(235/239,98.33%).The positive rates were 9.04%,18.76 % and 17.75 % respectively for the year of 2005,2006 and 2007.74.48% of the strains were isolated from patients older than 60 years.The median length of hospitalization was 23 days.The drug resistance rates to 13 clinical used antibiotics increased year by year.Conclusion There was an increasing trend in detection rate and drug resistance strains of Acinetobacter baumannii from ICU patients.The results suggested the necessary of strict standards of ICU hospitalization,reasonable application of antimicrobial agents,complete disinfection and hand hygiene of medical staff.
出处 《中国预防医学杂志》 CAS 2010年第6期608-609,共2页 Chinese Preventive Medicine
关键词 重症监护病房 鲍曼不动杆菌 耐药性 Intensive care unit(ICU) Acinetobacter baumanni Drug resistance
  • 相关文献

参考文献4

二级参考文献34

共引文献254

同被引文献22

  • 1徐丽萍,陈泰来,陈莲萍.292株鲍曼不动杆菌耐药性分析[J].浙江预防医学,2009,21(2):3-4. 被引量:14
  • 2张樱,陈亚岗,杨青.不动杆菌感染及耐药机制的研究进展[J].国外医学(流行病学.传染病学分册),2005,32(2):109-112. 被引量:93
  • 3Yoon J, Urban C, Terzian C, et al. In vitro dou/3/e and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Aeinetohacter baumannii [J].mimicrob Agents Chemother, 2004,48 (3) : 753.
  • 4van Looveren M, Goossens H. Antimierobial resistance of Acinetobacter spp in Europe[J]. Clin Microbiol Infect, 2004,10 (8) :684-704.
  • 5Pateh M, Weinheimer JD, Waites KB, et al. Active surveil lance to determine the impact of methicillin - resistant Sta phy-lococcus aurens colonization on patients in intensive care units of a Veterans Affairs Medical Center [J].Infect Control HospEpidemiol, 2008, 29 (6): 503- 509.
  • 6Rebmann T,Rosenbaum PA.Preventing the transmission of multi-drug-resistant Acinetobacter Baumannii:an executive summary ofthe Association for Professionals in Infection control and epidemiolo-gy's elimination guide[J].Am J Infect Control,2011,39(5):439.
  • 7Rodriguez-Bano J, Marti S, Soto S, et al. Biofilm formation in Acin- etebacter baumannii: associated features and clinical implications [ J]. Clin Microbiol Infect ,2008,14:276-278.
  • 8Rodriguez-Bano J,Cisneros JM, Fernandez-Cuenca F, et al. Clini- cal features and epidemiology of Acinetobacter haumannii coloniza- tion and infection in Spanish hospitals[ J]. Infect Control Hosp Ep- idemio1,2004,25:819-824.
  • 9Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial blood- stream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study [ J ]. Clin Infect Dis, 2004,39 : 309-317.
  • 10Falagas ME, Bliziotis IA, Siempos II. Attributable morality of Acinetobacter baumannii infections in critically ill patients: a sys- tematic review of matched cohort and case-control studies[ J]. Crit Care ,2006,10 : R48.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部